![]() |
市場調查報告書
商品編碼
1813454
犬類微生物組飲食市場預測(至 2032 年):按產品類型、配方、生命階段、分銷管道、最終用戶和地區進行的全球分析Canine Microbiome Diet Market Forecasts to 2032 - Global Analysis By Product Type, Formulation, Life Stage, Distribution Channel, End User and By Geography |
根據 Stratistics MRC 的數據,全球犬類微生物組飲食市場預計在 2025 年達到 3,180 萬美元,到 2032 年將達到 5,970 萬美元,預測期內的複合年成長率為 9.4%。
犬類微生物組飲食是一種營養方法,旨在支持和最佳化愛犬的腸道微生物組。它強調以動物性蛋白質和健康脂肪為主,以物種適宜、加工程度最低的食物為主,同時限制碳水化合物和人工添加劑的攝取。該飲食旨在增加微生物多樣性,改善消化功能,增強免疫功能,並減少發炎。透過與愛犬祖先的飲食保持一致,它能夠促進腸道菌群平衡,從而促進整體健康,增強對代謝和胃腸道疾病的抵抗力。
寵物的人性化、健康意識和獸醫意識的提高
人們日益意識到腸道健康與免疫力、行為和慢性疾病之間的關聯,這推動了針對微生物組的飲食需求。獸醫擴大推薦富含益生菌的配方和個人化營養計劃,這些產品也已獲得臨床驗證。微生物組定序和糞便檢驗的創新使得個人化干預措施成為可能,進一步推動了市場應用。寵物健康與科學檢驗的融合正在為成長奠定堅實的基礎。
消費者懷疑論與教育不平等
由於對腸道微生物組及其在犬類健康中的作用了解有限,消費者不願放棄傳統寵物食品。缺乏標準化的標籤和不一致的產品宣傳進一步加劇了消費者的決策難度。此外,微生物組相互作用的科學複雜性使其難以用簡單的術語進行溝通,阻礙了其大規模普及。如果沒有針對性的教育宣傳活動和透明的產品溝通,市場滲透率很可能仍限於小眾市場。
透過電子商務和DTC管道擴張
電商和DTC模式讓品牌能夠突破傳統零售的限制,提供個人化、訂閱式的微生物組飲食。這些管道有助於資料收集,使企業能夠根據客戶回饋和寵物健康狀況改進配方。線上平台也支持教育內容,有助於填補知識空白並建立信任。隨著消費者對便利性和客製化的需求日益成長,數位優先策略正在釋放新的收益來源並加速市場擴張。
與傳統寵物食品品牌的競爭
現有的寵物食品製造商正以激進的定價和廣泛的分銷網路進軍功能性營養領域,這對利基微生物組飲食供應商構成了挑戰。這些傳統品牌通常擁有強大的品牌認知度和消費者忠誠度,這使得新興企業難以脫穎而出。此外,一些傳統產品正被重新包裝,並宣稱含有膚淺的益生菌成分,這削弱了科學配方的微生物組飲食的價值。
疫情改變了寵物飼養習慣,提高了寵物擁有率,也增強了人們對寵物健康的關注。由於疫情封鎖導致獸醫就診減少,飼主主人轉向居家健康解決方案,包括預防性營養和微生物組飲食。雖然供應鏈中斷最初影響了原料採購和產品供應,但線上寵物護理產品購買量的激增抵消了這些挑戰。這場危機也加速了人們對免疫力增強配方的興趣,這與微生物組飲食的核心益處相符。
預計功能性狗糧市場在預測期內將佔最大佔有率
功能性狗糧市場預計將在預測期內佔據最大市場佔有率,這得益於其廣泛的吸引力和已證實的健康益處。這些產品通常添加益生元、益生菌和後生元,以支持消化平衡、免疫功能和營養吸收。該市場受益於臨床研究和獸醫建議的進步,成為注重健康的飼主的可靠選擇。功能性食品針對過敏、肥胖和焦慮等特定情況量身定做,擴大了其效用。
預計預測期內粉末、咀嚼物和零食部分將以最高的複合年成長率成長。
由於便利性、偏好和精準投放,預計粉末、咀嚼和零食細分市場將在預測期內實現最高成長率。這些形式可以精確地添加支持微生物的成分,並且通常比傳統的粗磨食物更容易管理。封裝和掩味遮罩的創新正在提高寵物對產品的接受度,飼主也欣賞這種將補充劑靈活地添加到現有飲食中的靈活性。
受寵物擁有量成長、都市化和可支配收入成長的推動,預計亞太地區將在預測期內佔據最大的市場佔有率。中國、日本和韓國等國家對高階寵物營養品(包括微生物強化飼料)的需求正在激增。該地區的企業正在投資本地生產和根據當地文化量身定做的配方,而全球品牌則透過策略合作夥伴關係擴大其影響力。獸醫基礎設施正在改善,宣傳宣傳活動也勢頭強勁,為市場擴張創造了肥沃的土壤。
預計北美在預測期內將呈現最高的複合年成長率,這得益於其先進的獸醫護理、高昂的寵物醫療保健支出以及濃厚的寵物健康文化。該地區擁有多家專注於微生物組科學的生物技術新興企業和研究機構,推動產品創新和臨床檢驗。消費者對透明度、永續性和實證營養的要求日益提高,這與微生物組飲食的概念相符。法律規範也在不斷發展,以支持功能性聲明,鼓勵投資和產品多樣化。
According to Stratistics MRC, the Global Canine Microbiome Diet Market is accounted for $31.8 million in 2025 and is expected to reach $59.7 million by 2032 growing at a CAGR of 9.4% during the forecast period. Canine Microbiome Diet is a nutritional approach designed to support and optimizes the gut microbiota in dogs. It emphasizes species-appropriate, minimally processed foods primarily animal proteins and healthy fats while limiting carbohydrates and artificial additives. This diet aims to enhance microbial diversity, improve digestion, strengthen immune function, and reduce inflammation. By aligning with the canine ancestral diet, it fosters eubiosis, a balanced microbial state that promotes overall health and resilience against metabolic and gastrointestinal disorders
Pet humanization, health awareness and growing veterinary recognition
Rising awareness of gut health and its link to immunity, behavior, and chronic conditions is driving demand for microbiome-targeted diets. Veterinarians are increasingly recommending probiotic-rich formulations and personalized nutrition plans, validating the clinical relevance of these products. Innovations in microbiome sequencing and fecal testing are enabling tailored interventions, further boosting market adoption. The convergence of pet wellness and scientific validation is creating a robust foundation for growth.
Consumer skepticism and education gap
Limited understanding of gut flora and its role in canine health contributes to hesitation in switching from conventional pet food. The lack of standardized labeling and inconsistent product claims further complicates consumer decision-making. Additionally, the scientific complexity of microbiome interactions is difficult to communicate in simple terms, creating a barrier to mass adoption. Without targeted educational campaigns and transparent product communication, market penetration may remain confined to niche segments.
Expansion in E-commerce and direct-to-consumer (DTC) channels
E-commerce and DTC models allow brands to bypass traditional retail constraints and offer personalized subscription-based microbiome diets. These channels facilitate data collection, enabling companies to refine formulations based on customer feedback and pet health outcomes. Online platforms also support educational content, helping bridge the knowledge gap and build trust. As consumers increasingly seek convenience and customization, digital-first strategies are unlocking new revenue streams and accelerating market reach.
Competition from traditional pet food brands
Established pet food manufacturers are entering the functional nutrition space with aggressive pricing and broad distribution networks, posing a challenge to niche microbiome diet providers. These legacy brands often have stronger brand recognition and consumer loyalty, making it difficult for emerging players to differentiate. Additionally, some conventional products are being rebranded with superficial probiotic claims, diluting the perceived value of scientifically formulated microbiome diets.
The pandemic reshaped pet ownership dynamics, with increased adoption rates and heightened attention to pet health. As veterinary visits declined due to lockdowns, owners turned to preventive nutrition and at-home wellness solutions, including microbiome-supportive diets. Supply chain disruptions initially affected ingredient sourcing and product availability, but the surge in online pet care purchases offset these challenges. The crisis also accelerated interest in immunity-boosting formulations, aligning with the core benefits of microbiome diets.
The functional dog food segment is expected to be the largest during the forecast period
The functional dog food segment is expected to account for the largest market share during the forecast period due to its broad appeal and proven health benefits. These products often incorporate prebiotics, probiotics, and postbiotics to support digestive balance, immune function, and nutrient absorption. The segment benefits from growing clinical research and veterinary endorsement, making it a trusted choice among health-conscious pet owners. Functional diets are also being tailored to address specific conditions such as allergies, obesity, and anxiety, expanding their utility.
The powders, chews & treats segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the powders, chews & treats segment is predicted to witness the highest growth rate driven by convenience, palatability, and targeted delivery. These formats allow for precise dosing of microbiome-supportive ingredients and are often easier to administer than traditional kibble. Innovations in encapsulation and flavor masking are improving product acceptance among pets, while owners appreciate the flexibility of integrating supplements into existing diets.
During the forecast period, the Asia Pacific region is expected to hold the largest market share fueled by rising pet ownership, urbanization, and growing disposable incomes. Countries like China, Japan, and South Korea are witnessing a surge in demand for premium pet nutrition, including microbiome-enhancing diets. Regional players are investing in local manufacturing and culturally tailored formulations, while global brands are expanding their footprint through strategic partnerships. Veterinary infrastructure is improving, and awareness campaigns are gaining momentum, creating fertile ground for market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to advanced veterinary care, high pet healthcare spending, and a strong culture of pet wellness. The region is home to several biotech startups and research institutions focused on microbiome science, driving product innovation and clinical validation. Consumers are increasingly seeking transparency, sustainability, and evidence-based nutrition, which aligns with the ethos of microbiome diets. Regulatory frameworks are also evolving to support functional claims, encouraging investment and product diversification.
Key players in the market
Some of the key players in Canine Microbiome Diet Market include Purina, Hill's Pet Nutrition, Inc., ADM (Archer Daniels Midland), AnimalBiome, Inc., CanBiocin Inc., NomNomNow Inc., Royal Canin, Iams (Spectrum Brands Holdings), Kemin Industries, Lallemand Inc., Cargill, Incorporated, Chr. Hansen Holding A/S, Evonik Industries AG, Novozymes A/S, Zoetis Inc., and Vetoquinol.
In July 2025, CanBiocin Inc. and Lesaffre published a joint press release in July 2025 announcing an expanded partnership with CanBiocin to broaden presence in the companion-animal care market. The collaboration is intended to expand distribution and commercial reach for CanBiocin's species-specific probiotic solutions.
In July 2025, Lallemand announced the acquisition of enzyme specialist Solyve (Switzerland) in July 2025 to reinforce its microbial and enzyme capabilities. The move expands Lallemand's enzyme portfolio and CDMO capabilities for food, feed and biotech customers.
In June 2025, Royal Canin announced the launch of "Royal Canin Fresh Health Nutrition" in mid-June 2025 as a gently cooked line tailored to specific health needs across life stages. The launch positions Royal Canin's first gently cooked offering as an innovation in tailored pet nutrition for health outcomes.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.